Calcitonin gene-related peptide causes long-term inhibition of contraction in rat thoracic aorta through a nitric oxide-dependent pathway

Neuropeptides

Volumn 33, Issue 2, 1999, Pages 145-154

  Lu, L F ^a   Fiscus, Ronald R ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; INTERLEUKIN 1BETA; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASODILATATION;

ANIMALIA;

EID: 0033120147     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0010     Document Type: Article

References (36)

1. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48-57.
2. Root RK, Jacob R. Septicaemia and septic shock. In: Wilson JD, Braunwald E, Isselbacher KJ, Harrison's Principles of Internal Medicine. 12th Ed. New York: Mcgraw-Hill, 1991: 502-507.
3. Parratt JR. Myocardial and circulatory effects of E. Coli endotoxin; modification of responses to catecholamines. Br J Pharmacol 1973; 47: 12-25.
4. Suffredini AF, Fromm RE, Parker MM et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280-287.
5. Hall RC, Hodge RL. Vasoactive hormones in endotoxin shock: A comparative study in cats and dogs. J Physiol (Lond). 1971; 213: 69-84.
6. Parratt JR, Sturgess RM. E. Coli endotoxin shock in the cat; treatment with indomethacin. Br J Pharmacol 1975; 53: 485-488.
7. Boughton-Smith NK, Hutcheson I, Whittle BJ. Relationship between paf-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins 1989; 38: 319-333.
8. Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, Shen TY. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with paf-receptor antagonist kadsurenone. Biochem Biophys Res Commun 1985; 127, No. 3: 799-808.
9. Fletcher JR, Ramwell PW, Harris RH. Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock. Advances in Shock Research 1981; 5: 143-148: 143-148.
10. Cook JA, Wise WC, Halushka PV. Elevated thrombaxane levels in the rat during endotoxic shock. Protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest 1980; 65: 227-230.
11. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun. 1989; 161: 1220-1227.
12. Beasley D, Cohen RA, Levinsky NG. Interleukin-1 inhibits contraction of vascular smooth muscle. J Clin Invest 1989; 83: 331-335.
13. McKenna TM. Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release. J Clin Invest 1990; 86: 160-168.
14. Tracey KJ, Fong Y, Hesse DG et al. Anti-cachectin/tnf monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 662-664.
15. Wang X, Jones SB, ZHou Z, Han C, Fiscus RR. Calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY) levels are elevated in plasma and decreased in vena cava during endotoxic shock in the rat. Circ Shock 1992; 36: 21-30.
16. Arden WA, Fiscus RR, Wang X et al. Elevations in circulating calcitonin gene-related peptide correlate with hemodynamic deterioration during endotoxic shock in pigs. Circ Shock 1994; 42: 147-153.
17. Joyce CD, Fiscus RR, Wang X, Dries DJ, Morris RC, Prinz RA. Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery 1990; 108: 1097-1101.
18. Wang X, Han C, Jones SB, Yang L, Fiscus RR. Calcitonin gene-related peptide release in endotoxicosis may be mediated by prostaglandins. Shock 1995; 3: 34-39.
19. Wang X, Fiscus RR. Lactic acid potentiates bradykinin-and low ph-induced release of CGRP from rat spinal cord slices. Am J Physiol 1997; 273 (Endocrinol. 36): E92-E98.
20. Wang X, Wu Z, Tang Y, Fiscus RR, Han C. Rapid nitric oxide-and prostaglandin-dependent release of calcitonin gene-related peptide (CGRP) triggered by endotoxin in rat mesenteric arterial bed. Br J Pharmacol 1996; 118: 2164-2170.
21. Uddman R, Edvinsson L, EKblad E, Hakanson R, Sundler F. Calcitonin gene-related peptide (CGRP): Perivascular distribution and vasodilatory effects. Regul Pept. 1986; 15: 1-23.
22. Huttemeier PC, Ritter EF, Benveniste H. Calcitonin gene-related peptide mediates hypotension and tachycardia in endotoxic rats. Am J Physiol 1993; 265: H767-H769.
23. Fiscus RR. Molecular mechanisms of endothelium-mediated vasodilation. Sem Thromb Hemost 1988; Supplement 14: 12-22.
24. Fiscus RR, Zhou HL, Wang X et al. Calcitonin gene-related peptide (CGRP)-induced cyclic AMP, cyclic GMP and vasorelaxant responses in rat thoracic aorta are antagonized by blockers of endothelium-derived relaxant factor (EDRF). Neuropeptides 1991; 20 (2): 133-143.
25. Libby P, Ordovas JM, Birinyl LK, Auger KR, Dinarello CA. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest 1986; 78: 1432-1438.
26. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988; 81: 1162-1172.
27. French JF, Lambert LE, Dage DC. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle. J Pharmacol Exp Ther 1991; 259: 260-264.
28. Beasley D, Schwartz JH, Brenner BM. Interleukin 1 induces prolonged l-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87: 602-608.
29. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M. Cyclic amp-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J Biol Chem 1993; 268: 24959-24966.
30. Marumo T, Nakaki T, Hishikawa K et al. Natriuretic peptide-augmented induction of nitric-oxide synthase through cyclic guanosine 3′, 5′-monophosphate elevation in vascular smooth muscle cells. Endocrinology 1995; 136: 2135-2142.
31. Schini-Kerth VB, Fisslthaler B, Busse R. CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cAMP-dependent mechanism. Am J Physiol 1994; 267: H2483- H2490.
32. Sirsjo A, Soderkvist P, Sundqvist T, Carlsson M, Ost M, Gidlof A. Different induction mechanisms of mRNA for inducible nitric oxide synthase in rat smooth muscle cells in culture and in aortic strips. FEBS Lett 1994; 338: 191-196.
33. Imai T, Hirata Y, KAnno K, Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest 1994; 93: 543-549.
34. Durante W, Cheng K, Schafer AI. Cyclic nucleotide regulation of interleukin-1 beta induced nitric oxide synthase expression in vascular smooth muscle cells. Thromb Res 1994; 75: 63-71.
35. Inoue T, Fukuo K, Nakahashi T, Hata S, Morimoto S, Ogihara T. cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells. Hypertension 1995; 25: 711-714.
36. ω-nitro-l-arginine inhibits vasodilations and elevations of both cyclic AMP and cyclic GMP levels in rat aorta induced by calcitonin gene-related peptide (CGRP). Neuropeptides 1994; 26: 123-131.